Vaccination in Individuals with Multiple Sclerosis – Part II

Basit Öğe Kaydı
dc.authorscopusid57314080400
dc.authorscopusid57195979263
dc.authorscopusid57205507893
dc.authorscopusid57225924847
dc.authorscopusid55826416500
dc.authorscopusid58223287900
dc.authorscopusid26666613100
dc.contributor.authorPiri Çınar B.
dc.contributor.authorTuncer A.
dc.contributor.authorBilge N.
dc.contributor.authorBünül S.D.
dc.contributor.authorGözübatık-çelik R.G.
dc.contributor.authorÇiftçi E.D.
dc.contributor.authorGenç G.
dc.date.accessioned2024-03-09T19:40:02Z
dc.date.available2024-03-09T19:40:02Z
dc.date.issued2023
dc.departmentİzmir Bakırçay Üniversitesien_US
dc.description.abstractMultiple sclerosis (MS) is an autoimmune and demyelinating disease of the central nervous system. It is a chronic disease, and in the evaluation of all other health and vital processes, decisions about vaccination should be made considering the disease process and the medications used by the patient. Since vaccination can be performed at any stage of life, immune system activity should be reviewed in patients with MS except where it is characteristic of the vaccine. In this review, the applications of different vaccines in patients with MS are discussed in two separate sections (part 1 was published in the previous issue). © 2023 by the Turkish Neurological Society.en_US
dc.identifier.doi10.4274/tnd.2023.16984
dc.identifier.endpage94en_US
dc.identifier.issn1301-062X
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85163629064en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage85en_US
dc.identifier.trdizinid1189506en_US
dc.identifier.urihttps://doi.org/10.4274/tnd.2023.16984
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1189506
dc.identifier.urihttps://hdl.handle.net/20.500.14034/1638
dc.identifier.volume29en_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.publisherTurkish Neurosurgical Societyen_US
dc.relation.ispartofTurk Noroloji Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectMultiple sclerosis; safety; vaccinationen_US
dc.subjectalemtuzumab; chickenpox vaccine; corticosteroid; fingolimod; hemagglutinin; influenza vaccine; ocrelizumab; ofatumumab; ravulizumab; rituximab; smallpox vaccine; teriflunomide; virus vaccine; antibody response; autoimmune disease; autoimmune disease of the central nervous system; cardiovascular disease; chronic kidney failure; condyloma acuminatum; demyelinating disease; disease activity; hemoglobinopathy; herd immunity; hospitalization; human; immune response; immunosuppressive treatment; liquorrhea; malaise; multiple sclerosis; myalgia; neuropathic pain; palliative therapy; papillomatosis; postherpetic neuralgia; Review; seroconversion; vaccination; viremiaen_US
dc.titleVaccination in Individuals with Multiple Sclerosis – Part IIen_US
dc.title.alternativeMultipl Skleroz Tanılı Bireylerde Aşılama – Bölüm IIen_US
dc.typeReview Articleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
1638.pdf
Boyut:
148.91 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu